Indo Us Biotech: Unaudited Financial Results for the quarter ended on 30-09-2026
Indo Us Biotech (INDOUS) filed a disclosure titled "Unaudited Financial Results for the quarter ended on 30-09-2026". The company is valued at about ₹174 crore.
What happened
Indo Us Biotech (INDOUS) filed a disclosure with the exchanges on 30 October 2026 at 04:18 PM titled "Unaudited Financial Results for the quarter ended on 30-09-2026".
Company snapshot
Indo Us Biotech is a micro-cap company, with a market value of about ₹174 crore.
The stock last traded at ₹86.84, against a 52-week range of ₹57.5–₹159 (45.4% below the high).
Before this filing the shares had moved +11.9% over the month and +3.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.2 crore.
Promoters held 68.29% at the end of Q1 FY27. Foreign institutions owned 0.01% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 31 | 4.7 | 2.35 |
| Q2 FY26 | 62 | 8.2 | 4.06 |
| Q3 FY26 | 23 | 3 | 1.49 |
| Q4 FY26 | 26 | 2 | 0.98 |
| Q1 FY27 | 33 | 3 | 1.51 |
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock fell 1.1% on average the next trading day and was down 0.3% on average after five days (3 filings with price data).
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 12 Aug 2026 | Submission of Standalone Unaudited Financial Results of the Company… | +0.7% | +6.8% |
| 29 May 2026 | Integrated Filling_Finacial Results for the year 31-03-2026 | −1.9% | −3.8% |
| 29 May 2026 | , the financial results for the period ended March 31, 2026. | −1.9% | −3.8% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.